Patient-reported outcomes with the (3)-adrenoceptor agonist mirabegron in a phase III trial in patients with overactive bladder

Khullar Vik; Amarenco Gerard; Angulo Javier C.; Blauwet Mary Beth; Nazir Jameel; Odeyemi Isaac A.; Hakimi Zalmai

首页> 外文期刊>Neurourology and urodynamics. >Patient-reported outcomes with the (3)-adrenoceptor agonist mirabegron in a phase III trial in patients with overactive bladder

【24h】

Patient-reported outcomes with the (3)-adrenoceptor agonist mirabegron in a phase III trial in patients with overactive bladder

机译：在膀胱过度活动症患者的III期临床试验中，患者报告了（3）-肾上腺素受体激动剂米拉贝隆的治疗结果

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

AimsTo assess patient-reported outcomes (PROs) in patients with overactive bladder (OAB) receiving the novel (3)-adrenoceptor agonist mirabegron.

机译：目的评估接受新型（3）-肾上腺素受体激动剂米拉贝隆治疗的膀胱过度活动症（OAB）患者的患者报告的结局（PRO）。

著录项

来源
《Neurourology and urodynamics.》 |2016年第8期|共8页
作者
Khullar Vik; Amarenco Gerard; Angulo Javier C.; Blauwet Mary Beth; Nazir Jameel; Odeyemi Isaac A.; Hakimi Zalmai;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词
(3)-adrenoceptor agonist; overactive bladder (OAB); patient outcome assessment; quality of life;

机译：（3）肾上腺素受体激动剂;膀胱过度活动症;患者预后评估;生活质量;

相似文献

外文文献
中文文献
专利

1. Patient-reported outcomes with the (3)-adrenoceptor agonist mirabegron in a phase III trial in patients with overactive bladder [J] . Khullar Vik, Amarenco Gerard, Angulo Javier C., Neurourology and urodynamics. . 2016,第8期

机译：在膀胱过度活动症患者的III期临床试验中，患者报告了（3）-肾上腺素受体激动剂米拉贝隆的治疗结果
2. Onset of action of the beta 3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder [J] . Chapple Christopher R., Nitti Victor W., Khullar Vik, World journal of urology . 2014,第6期

机译：β3-肾上腺素受体激动剂米拉贝隆在膀胱过度活动症患者的II期和III期临床试验中起效
3. Critical analysis of phase II and III randomised control trials (RCTs) evaluating efficacy and tolerability of a beta(3)-adrenoceptor agonist (Mirabegron) for overactive bladder (OAB) [J] . Rossanese Marta, Novara Giacomo, Challacombe Ben, BJU international . 2015,第1期

机译：评估II期和III期随机对照试验（RCT）评估β（3）-肾上腺素受体激动剂（Mirabegron）对膀胱过度活动症（OAB）的疗效和耐受性的关键分析
4. Electrical Stimulation of the Transcutaneous Posterior Tibial Nerve for the Treatment of Patients with Detrusor Overactivity Due to Neurogenic Hiperactive Bladder in Multiple Sclerosis A Case Study [C] . Fabiana S. B. Perez, Luciana R. Tenorio Peixoto, Fabiano Soares, International Conference on Biomedical Electronics and Devices . 2014

机译：经皮后胫骨神经的电气刺激治疗多发性硬化中神经源性膀胱患者患者的患者案例研究
5. An Evaluation of Hypertension Control in the US Population and Patient-Reported Outcomes in a Clinical Trial of Heart Failure. [D] . Dinkler, John Michael. 2016

机译：在美国人群中进行的高血压控制评估和心力衰竭临床试验中患者报告的结果。
6. Onset of action of the β3-adrenoceptor agonist mirabegron in Phase II and III clinical trials in patients with overactive bladder [O] . Christopher R. Chapple, Victor W. Nitti, Vik Khullar, -1

机译：β3-肾上腺素受体激动剂米拉贝隆在膀胱过度活动症患者的II期和III期临床试验中起效
7. Patient-reported outcomes with the β3-adrenoceptor agonist mirabegron in a phase III trial in patients with overactive bladder [O] . Khullar V, Amarenco G, Angulo JC, 2015

机译：膀胱过度活动症患者III期试验中β3-肾上腺素能受体激动剂mirabegron的患者报告结果

Patient-reported outcomes with the (3)-adrenoceptor agonist mirabegron in a phase III trial in patients with overactive bladder

摘要

著录项

相似文献

相关主题

期刊订阅